Aberrant expression of a five-microRNA signature in breast carcinoma as a promising biomarker for diagnosis.
Amirreza BitarafSadegh BabashahMasoud GarshasbiPublished in: Journal of clinical laboratory analysis (2019)
The present findings suggested that dysregulation of this five-miRNA signature might be considered as a promising and functional biomarker for BC diagnosis.
Keyphrases